These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23627311)

  • 1. Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.
    Santangelo Freel RM; Ogden KK; Strong KL; Khatri A; Chepiga KM; Jensen HS; Traynelis SF; Liotta DC
    J Med Chem; 2013 Jul; 56(13):5351-81. PubMed ID: 23627311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators.
    Zimmerman SS; Khatri A; Garnier-Amblard EC; Mullasseril P; Kurtkaya NL; Gyoneva S; Hansen KB; Traynelis SF; Liotta DC
    J Med Chem; 2014 Mar; 57(6):2334-56. PubMed ID: 24512267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors.
    Strong KL; Epplin MP; Bacsa J; Butch CJ; Burger PB; Menaldino DS; Traynelis SF; Liotta DC
    J Med Chem; 2017 Jul; 60(13):5556-5585. PubMed ID: 28586221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel family of negative and positive allosteric modulators of NMDA receptors.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
    Swanger SA; Vance KM; Acker TM; Zimmerman SS; DiRaddo JO; Myers SJ; Bundgaard C; Mosley CA; Summer SL; Menaldino DS; Jensen HS; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2018 Feb; 9(2):306-319. PubMed ID: 29043770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
    Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
    Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
    Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H
    Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-Specific Agonists for NMDA Receptor Glycine Binding Sites.
    Maolanon AR; Risgaard R; Wang SY; Snoep Y; Papangelis A; Yi F; Holley D; Barslund AF; Svenstrup N; Hansen KB; Clausen RP
    ACS Chem Neurosci; 2017 Aug; 8(8):1681-1687. PubMed ID: 28514141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
    Hansen KB; Tajima N; Risgaard R; Perszyk RE; Jørgensen L; Vance KM; Ogden KK; Clausen RP; Furukawa H; Traynelis SF
    Mol Pharmacol; 2013 Jul; 84(1):114-27. PubMed ID: 23625947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists.
    Acker TM; Khatri A; Vance KM; Slabber C; Bacsa J; Snyder JP; Traynelis SF; Liotta DC
    J Med Chem; 2013 Aug; 56(16):6434-56. PubMed ID: 23909910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit.
    Volkmann RA; Fanger CM; Anderson DR; Sirivolu VR; Paschetto K; Gordon E; Virginio C; Gleyzes M; Buisson B; Steidl E; Mierau SB; Fagiolini M; Menniti FS
    PLoS One; 2016; 11(2):e0148129. PubMed ID: 26829109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of AICP as a GluN2C-Selective
    Jessen M; Frederiksen K; Yi F; Clausen RP; Hansen KB; Bräuner-Osborne H; Kilburn P; Damholt A
    Mol Pharmacol; 2017 Aug; 92(2):151-161. PubMed ID: 28588066
    [No Abstract]   [Full Text] [Related]  

  • 14. Subunit-dependent inhibition of recombinant rodent N-methyl-D-aspartate receptors by a HIV-1 glycoprotein 120 derived peptide.
    Wittekindt B; Betz H; Laube B
    Neurosci Lett; 2000 Feb; 280(2):151-4. PubMed ID: 10686400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.
    Yi F; Rouzbeh N; Hansen KB; Xu Y; Fanger CM; Gordon E; Paschetto K; Menniti FS; Volkmann RA
    Neuropharmacology; 2020 Aug; 173():107971. PubMed ID: 31987864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner.
    Edman S; McKay S; Macdonald LJ; Samadi M; Livesey MR; Hardingham GE; Wyllie DJ
    Neuropharmacology; 2012 Sep; 63(3):441-9. PubMed ID: 22579927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations.
    Zhang L; Peoples RW; Oz M; Harvey-White J; Weight FF; Brauneis U
    J Neurophysiol; 1997 Aug; 78(2):582-90. PubMed ID: 9307096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors.
    Riou M; Stroebel D; Edwardson JM; Paoletti P
    PLoS One; 2012; 7(4):e35134. PubMed ID: 22493736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of l-Theanine Excitatory Actions on Hippocampal Neurons: Toward the Generation of Novel N-Methyl-d-aspartate Receptor Modulators Based on Its Backbone.
    Sebih F; Rousset M; Bellahouel S; Rolland M; de Jesus Ferreira MC; Guiramand J; Cohen-Solal C; Barbanel G; Cens T; Abouazza M; Tassou A; Gratuze M; Meusnier C; Charnet P; Vignes M; Rolland V
    ACS Chem Neurosci; 2017 Aug; 8(8):1724-1734. PubMed ID: 28511005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.
    Chatterton JE; Awobuluyi M; Premkumar LS; Takahashi H; Talantova M; Shin Y; Cui J; Tu S; Sevarino KA; Nakanishi N; Tong G; Lipton SA; Zhang D
    Nature; 2002 Feb; 415(6873):793-8. PubMed ID: 11823786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.